期刊文献+

Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia 被引量:7

Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia
下载PDF
导出
摘要 AIM:To determine the expression of neurokinin-1receptor(NK-1R),phosphorylated epidermal growth factor receptor(p EGFR),cyclooxygenase-2(Cox-2),and vitamin D receptor(VDR)in normal,inflammatory bowel disease(IBD),and colorectal neoplasia tissues from Puerto Ricans.METHODS:Tissues from patients with IBD,colitisassociated colorectal cancer(CAC),sporadic dysplasia,and sporadic colorectal cancer(CRC),as well as normal controls,were identified at several centers in Puerto Rico.Archival formalin-fixed,paraffin-embedded tissues were de-identified and processed by immunohistochemistry for NK-1R,p EGFR,Cox-2,and VDR.Pictures of representative areas of each tissues diagnosis were taken and scored by three observers using a4-point scale that assessed intensity of staining.Tissues with CAC were further analyzed by photographing representative areas of IBD and the different grades of dysplasia,in addition to the areas of cancer,within each tissue.Differences in the average age between the five patient groups were assessed with one-way analysis of variance and Tukey-Kramer multiple comparisons test.The mean scores for normal tissues and tissues with IBD,dysplasia,CRC,and CAC were calculatedand statistically compared using one-way analysis of variance and Dunnett’s multiple comparisons test.Correlations between protein expression patterns were analyzed with the Pearson’s product-moment correlation coefficient.Data are presented as mean±SE.RESULTS:On average,patients with IBD were younger(34.60±5.81)than normal(63.20±6.13,P<0.01),sporadic dysplasia(68.80±4.42,P<0.01),sporadic cancer(74.80±4.91,P<0.001),and CAC(57.50±5.11,P<0.05)patients.NK-1R in cancer tissue(sporadic CRC,1.73±0.34;CAC,1.57±0.53)and sporadic dysplasia(2.00±0.45)were higher than in normal tissues(0.73±0.19).p EGFR was significantly increased in sporadic CRC(1.53±0.43)and CAC(2.25±0.47)when compared to normal tissue(0.07±0.25,P<0.05,P<0.001,respectively).Cox-2 was significantly increased in sporadic colorectal cancer(2.20±0.23 vs 0.80±0.37 for normal tissues,P<0.05).In comparison to normal(2.80±0.13)and CAC(2.50±0.33)tissues,VDR was significantly decreased in sporadic dysplasia(0.00±0.00,P<0.001 vs normal,P<0.001 vs CAC)and sporadic CRC(0.47±0.23,P<0.001 vs normal,P<0.001 vs CAC).VDR levels negatively correlated with NK-1R(r=-0.48)and p EGFR(r=-0.56)in normal,IBD,sporadic dysplasia and sporadic CRC tissue,but not in CAC.CONCLUSION:Immunohistochemical NK-1R and p EGFR positivity with VDR negativity can be used to identify areas of sporadic colorectal neoplasia.VDR immunoreactivity can distinguish CAC from sporadic cancer. AIM:To determine the expression of neurokinin-1receptor(NK-1R),phosphorylated epidermal growth factor receptor(p EGFR),cyclooxygenase-2(Cox-2),and vitamin D receptor(VDR)in normal,inflammatory bowel disease(IBD),and colorectal neoplasia tissues from Puerto Ricans.METHODS:Tissues from patients with IBD,colitisassociated colorectal cancer(CAC),sporadic dysplasia,and sporadic colorectal cancer(CRC),as well as normal controls,were identified at several centers in Puerto Rico.Archival formalin-fixed,paraffin-embedded tissues were de-identified and processed by immunohistochemistry for NK-1R,p EGFR,Cox-2,and VDR.Pictures of representative areas of each tissues diagnosis were taken and scored by three observers using a4-point scale that assessed intensity of staining.Tissues with CAC were further analyzed by photographing representative areas of IBD and the different grades of dysplasia,in addition to the areas of cancer,within each tissue.Differences in the average age between the five patient groups were assessed with one-way analysis of variance and Tukey-Kramer multiple comparisons test.The mean scores for normal tissues and tissues with IBD,dysplasia,CRC,and CAC were calculatedand statistically compared using one-way analysis of variance and Dunnett’s multiple comparisons test.Correlations between protein expression patterns were analyzed with the Pearson’s product-moment correlation coefficient.Data are presented as mean±SE.RESULTS:On average,patients with IBD were younger(34.60±5.81)than normal(63.20±6.13,P<0.01),sporadic dysplasia(68.80±4.42,P<0.01),sporadic cancer(74.80±4.91,P<0.001),and CAC(57.50±5.11,P<0.05)patients.NK-1R in cancer tissue(sporadic CRC,1.73±0.34;CAC,1.57±0.53)and sporadic dysplasia(2.00±0.45)were higher than in normal tissues(0.73±0.19).p EGFR was significantly increased in sporadic CRC(1.53±0.43)and CAC(2.25±0.47)when compared to normal tissue(0.07±0.25,P<0.05,P<0.001,respectively).Cox-2 was significantly increased in sporadic colorectal cancer(2.20±0.23 vs 0.80±0.37 for normal tissues,P<0.05).In comparison to normal(2.80±0.13)and CAC(2.50±0.33)tissues,VDR was significantly decreased in sporadic dysplasia(0.00±0.00,P<0.001 vs normal,P<0.001 vs CAC)and sporadic CRC(0.47±0.23,P<0.001 vs normal,P<0.001 vs CAC).VDR levels negatively correlated with NK-1R(r=-0.48)and p EGFR(r=-0.56)in normal,IBD,sporadic dysplasia and sporadic CRC tissue,but not in CAC.CONCLUSION:Immunohistochemical NK-1R and p EGFR positivity with VDR negativity can be used to identify areas of sporadic colorectal neoplasia.VDR immunoreactivity can distinguish CAC from sporadic cancer.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第6期1749-1758,共10页 世界胃肠病学杂志(英文版)
基金 Supported by National Institutes of Health Grants,No.U56 CA126379(to Isidro AA and Appleyard CB)and No.R25-GM082406(to Isidro RA) National Science Foundation:Puerto Rico Louis Stokes Alliance for Minority Participation,NSF Project No.0601843(to Isidro RA) The PSMHS Molecular Biology Core Lab,RCMI Grant No.RR003050/MD007579
关键词 Colitis Colon cancer DYSPLASIA NEUROKININ VITAMIN Colitis Colon cancer Dysplasia Neurokinin Vitamin
  • 相关文献

参考文献20

  • 1Noam Harpaz,Stephen C. Ward,Claudia Mescoli,Steven H. Itzkowitz,Alexandros D. Polydorides.Precancerous lesions in inflammatory bowel disease[J].Best Practice & Research Clinical Gastroenterology.2013(2)
  • 2Angelamaria Rizzo,Francesco Pallone,Giovanni Monteleone,Massimo Claudio Fantini.Intestinal inflammation and colorectal cancer:A doubleedged sword?[J].World Journal of Gastroenterology,2011,17(26):3092-3100. 被引量:26
  • 3Perry Stambolsky,Yuval Tabach,Giulia Fontemaggi,Lilach Weisz,Revital Maor-Aloni,Zahava Sigfried,Idit Shiff,Ira Kogan,Moshe Shay,Eyal Kalo,Giovanni Blandino,Itamar Simon,Moshe Oren,Varda Rotter.Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53[J]. Cancer Cell . 2010 (3)
  • 4William Ka Kei Wu,Joseph Jao Yiu Sung,Chung Wa Lee,Jun Yu,Chi Hin Cho.Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: An update on the molecular mechanisms[J].Cancer Letters.2010(1)
  • 5Harpaz, Noam,Polydorides, Alexandros D.Colorectal Dysplasia in Chronic Inflammatory Bowel Disease: Pathology, Clinical Implications, and Pathogenesis[J].Archives of Pathology & Laboratory Medicine.2010(6)
  • 6Koji Wada,Hiroaki Tanaka,Kiyoshi Maeda,Toru Inoue,Eiji Noda,Ryosuke Amano,Naoshi Kubo,Kazuya Muguruma,Nobuya Yamada,Masakazu Yashiro,Tetsuji Sawada,Bunzo Nakata,Masaichi Ohira,Kosei Hirakawa.Vitamin D receptor expression is associated with colon cancer in ulcerativecolitis[J]. Oncology Reports . 2009 (5)
  • 7R. E. Harris.Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung[J]. Inflammopharmacology . 2009 (2)
  • 8W.P. ter Beek,I. Biemond,E.S.M. Muller,M. van den Berg,C.B.H.W. Lamers.Substance P receptor expression in patients with inflammatory bowel disease[J]. Neuropeptides . 2007 (5)
  • 9Steven H. Itzkowitz.Molecular Biology of Dysplasia and Cancer in Inflammatory Bowel Disease[J]. Gastroenterology Clinics of North America . 2006 (3)
  • 10F. Esteban,M. Mu?oz,M. A. González-Moles,M. Rosso.A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage[J]. Cancer and Metastasis Reviews . 2006 (1)

二级参考文献1

共引文献34

同被引文献70

  • 1Danielle A Vieira-Lopes,Nadja L Pinheiro,Armando Sales,Adriana Ventura,Francisco G Araújo,Iracema D Gomes,Aparecida A Nascimento.Immunohistochemical study of the digestive tract of Oligosarcus hepsetus[J].World Journal of Gastroenterology,2013,19(12):1919-1929. 被引量:2
  • 2János P Kósa,Péter Horváth,János Wlfling,Dóra Kovács,Bernadett Balla,Péter Mátyus,Evelin Horváth,Gábor Speer,István Takács,Zsolt Nagy,Henrik Horváth,Péter Lakatos.CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells[J].World Journal of Gastroenterology,2013,19(17):2621-2628. 被引量:6
  • 3陈凡,林琳,张红杰,王涛,杨希宁.溃疡性结肠炎患者结肠黏膜肝细胞生长因子的表达意义[J].中华消化内镜杂志,2006,23(4):272-274. 被引量:3
  • 4Peter Laszlo Lakatos.Recent trends in the epidemiology of inflammatory bowel diseases:Up or down?[J].World Journal of Gastroenterology,2006,12(38):6102-6108. 被引量:47
  • 5Francis A. Farraye,Robert D. Odze,Jayne Eaden,Steven H. Itzkowitz.AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease[J].Gastroenterology.2010(2)
  • 6Imogen Nicholson,A. Mark Dalzell,Wael El-Matary.Vitamin D as a therapy for colitis: A systematic review[J].Journal of Crohn’s and Colitis.2012(4)
  • 7Roger Bouillon,Geert Carmeliet,Lieve Verlinden,Evelyne van Etten,Annemieke Verstuyf,Hilary F. Luderer,Liesbet Lieben,Chantal Mathieu,Marie Demay.Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice[J].Endocrine Reviews.2008(6)
  • 8Koji Wada,Hiroaki Tanaka,Kiyoshi Maeda,Toru Inoue,Eiji Noda,Ryosuke Amano,Naoshi Kubo,Kazuya Muguruma,Nobuya Yamada,Masakazu Yashiro,Tetsuji Sawada,Bunzo Nakata,Masaichi Ohira,Kosei Hirakawa.Vitamin D receptor expression is associated with colon cancer in ulcerativecolitis[J]. Oncology Reports . 2009 (5)
  • 9Cantorna,MT,Mahon,BD.Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Experimental Biology and Medicine . 2004
  • 10Alex Ulitsky,Ashwin N. Ananthakrishnan,Amar Naik,Sue Skaros,Yelena Zadvornova,David G. Binion,Mazen Issa.Vitamin D Deficiency in Patients With Inflammatory Bowel Disease: Association With Disease Activity and Quality of Life. Journal of Parenteral and Enteral Nutrition . 2011

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部